DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
The ICON and AGO Collaborators.
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.
The Lancet 2003; 361: 2099-2106
We do not assume any responsibility for the contents of the web pages of other providers.